Profile data is unavailable for this security.
About the company
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells for different tissue types; Lung (PulmoStem), Brain (CogniStem), Kidney (NephroStem), Skin (CutiStem). It allows for selecting the type of cell to be used for specific tissue. The company has developed a process - patented in all steps - which includes collection of amniotic fluid, with a medical device developed by Amniotics, followed by sorting and propagation of stem cells and packaging of product in ampoules in its own GMP facility. Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.
- Revenue in SEK (TTM)0.00
- Net income in SEK-30.87m
- Incorporated2015
- Employees9.00
- LocationAmniotics AB (publ)Medicon Village, Scheelevagen 2LUND 223 63SwedenSWE
- Websitehttps://www.amniotics.com/